Novo Nordisk loses two senior staff to alternative antibiotics firm
Swiss biotech company Micreos Pharmaceuticals, which is developing alternatives to antibiotics, has succeeded in its hunt for new upper-level employees for two newly established roles, poaching two employees from Novo Nordisk.
by albert rønning-andersson, translated by daniel pedersen
Swiss Micreos Pharmaceuticals, which develops new biological therapies against unwanted bacteria within a number of indications, has announced the hires for two new positions, chief business officer and chief development officer, a company press release reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
